FindTrial
Sign In

Study the efficacy of autoinoculation(procedure to implant something from oneself) therapy in molluscum contagiosum( a type of viral infection)

To Study of Autoinoculation Therapy in the Treatment of Molluscum Contagiosum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027627
Enrollment
50
Registered
2020-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B081- Molluscum contagiosum

Interventions

Intervention1: Autoinoculation therapy in the treatment of molluscum contagiosum: The procedure will be done under topical anaesthesia using all aseptic precautions. The base will be approached using

Sponsors

DrRPGMC TANDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients clinically diagnosed of having molluscum contagiosum attending the outdoor patient department of Dr. R.P.G.M.C TANDA at kangra h.p

Exclusion criteria

Exclusion criteria: Following patients will be excluded from the study Patients who do not consent. Lesions over atypical sites(eyelids and mucosa) Lactating mothers and pregnant females History of intake of immunomodulatory/immunosuppressive

Design outcomes

Primary

MeasureTime frame
Excellent 75% of lesions disappeared Good 51-75% of the lesions disappeared Average 26-50% of the lesions disappeared Poor 25% of the lesions disappeared at1st week, 3rd week ,5th week,8th 12th week Timepoint: Baseline,1st week,3rd week,8th week,12th week—

Secondary

MeasureTime frame
scarring,pain,erythema etcTimepoint: 1,3,8,12 weeks—

Countries

India

Contacts

Public ContactJyotshna Sharma

DR.R.P.G.M.C TANDA AT KANGRA H.P

hoddermatologytanda@gmail.com9418457647

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026